世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ピーナッツアレルギー治療薬の世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2022-2028年


Global Peanut Allergy Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

ピーナッツは、アナフィラキシーに最もよく関連する食物アレルゲンの一つです。アナフィラキシーは、突然死に至る可能性があり、早急な対応と治療が必要な状態です。 ハイライト COVID-19およびロシア・ウク... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年10月11日 US$5,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ピーナッツは、アナフィラキシーに最もよく関連する食物アレルゲンの一つです。アナフィラキシーは、突然死に至る可能性があり、早急な対応と治療が必要な状態です。

ハイライト
COVID-19およびロシア・ウクライナ戦争の影響による経済変化を考慮すると、世界のピーナッツアレルギー治療薬市場は、2023年から2028年の間に37.4%のCAGRで、2022年の推定9億5370万米ドルから2028年までに6416.9万米ドルに達すると予測されます。
米国は最大の消費地であり、2019年の消費市場シェアは45%近くに達しています。米国に次いで、欧州が2番目に大きな消費地で、消費市場シェアは31%です。
市場競争は激しい。Mylan、Bayer、UCB Pharma、J & J、Perrigo、上位5社で52%の市場シェアを獲得しています。

レポート範囲
本レポートは、読者がビジネス/成長戦略を策定し、市場の競争状況を評価し、現在の市場における自社のポジションを分析し、ピーナッツアレルギー治療薬に関するビジネス上の意思決定を行うのに役立つ、ピーナッツアレルギー治療薬の世界市場を定量/定性分析とともに包括的に提示することを目的としています。

ピーナッツアレルギー治療薬の市場規模、推計、予測は、2021年を基準年とし、2017年から2028年までの歴史と予測データを考慮し、収益(百万ドル)の単位で提供しています。当レポートでは、世界のピーナッツアレルギー治療薬市場を包括的に区分しています。また、タイプ別、流通チャネル別、プレイヤー別の製品に関する地域別市場規模も掲載しています。市場規模を推計する際には、COVID-19やロシア・ウクライナ戦争の影響も考慮しました。

市場をより深く理解するために、競合環境、主要な競合他社、それぞれの市場順位などのプロフィールを掲載しています。また、技術動向や新製品開発についても考察しています。
当レポートは、同市場におけるピーナッツアレルギー治療薬企業、新規参入企業、産業チェーン関連企業に対し、市場全体および企業別、製品タイプ別、流通チャネル別、地域別のサブセグメントにおける収益に関する情報を提供することで、その一助となります。

主要企業および市場シェアの洞察
本セクションでは、読者は競合する主要企業について理解を深めることができます。本レポートでは、革新的なトレンドと開発、製品ポートフォリオの強化、M&A、コラボレーション、新製品イノベーション、地域的拡大など、これらの参加企業がプレゼンスを維持するために行っている主要成長戦略を調査しています。事業戦略とは別に、本調査には現在の開発状況や主要財務情報も含まれています。読者はまた、期間2017-2022の企業による世界収益に関連するデータへのアクセスを取得します。この包括的なレポートは、確かに更新を維持し、彼らのビジネスで効果的な意思決定を行うためにクライアントに役立つだろう。調査レポートでレビューされている著名なプレーヤーは以下の通りです。
マイラン
バイエル
UCBファーマ
J&J社
ペリゴ
GSK
カレオ
アムニール・ファーマ
ALK アベロ
アイミュン セラピューティック
HUAPONT Pharm
アレルギー・セラピューティクス
アシットバイオテック
サノフィ
DBVテクノロジーズ
HAL アレルギー
イントロミューン・セラピューティック

製品タイプ別インサイト
世界市場をPeanut Allergy Therapeuticsのタイプ別に、2028年までの成長予測とともにお届けします。収益の見積もりは、ピーナッツアレルギー治療薬が企業によって調達されるサプライチェーンにおける価格に基づいています。
本レポートでは、各セグメントを調査し、過去のデータを用いて市場規模を提示しています。また、そのセグメントが将来もたらす可能性のある成長機会についても触れています。この研究は、タイプ別、および歴史的期間(2017-2022)と予測期間(2023-2028)の収益データを授けるものです。
ピーナッツアレルギー治療薬のタイプ別セグメント
エピネフリン注射剤
抗ヒスタミン剤
経口免疫療法
その他

アプリケーションインサイト
本レポートでは、過去期間(2017-2022年)および予測期間(2023-2028年)における流通チャネル別の市場規模(収益データ)を掲載しています。
また、ピーナッツアレルギー治療薬市場に影響を与える各分野の市場動向や消費者行動について概説し、これらが業界の今後にどのような影響を与えるかを解説しています。本レポートは、ピーナッツアレルギー治療薬市場を牽引する関連市場および消費者動向の把握にお役立ていただけます。
ピーナッツアレルギー治療薬の流通経路別セグメント
病院薬局
小売薬局
その他

地域別展望
本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域/国の成長を評価する際に、経済的、社会的、環境的、技術的、政治的な要因が考慮されています。読者はまた、2017年から2028年までの各地域および国の収益に手を触れることになります。
市場は、北米、ヨーロッパ、アジア太平洋、南米、中東&アフリカなど、様々な主要地域に区分されています。アメリカ、ドイツ、イギリス、イタリア、フランス、中国、日本、韓国、東南アジア、インドなどの主要国の詳細な分析は、地域セグメント内でカバーされる予定です。市場推定については、2021年を基準年としてデータを提供し、2022年の推定値と2028年の予測収益を提供する予定である。
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
ベネルクス
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域
中南米
メキシコ
ブラジル
アルゼンチン
ラテンアメリカのその他
中近東・アフリカ
トルコ
サウジアラビア
UAE
その他の中東・アフリカ

主要なドライバーと障壁
本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの道を阻むブロックとして機能する可能性のある抑制と課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うために支援します。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。
COVID-19とロシア・ウクライナ戦争影響力分析
このセクションの読者は、パンデミック、ポストパンデミック、ロシア・ウクライナ戦争の間に、ピーナッツアレルギー治療薬市場のシナリオが世界中でどのように変化したかを理解することができます。この研究は、需要、消費、輸送、消費者行動、サプライチェーン管理などの側面の変化を視野に入れて行われます。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要因を強調しています。

本レポートを購入する理由
本レポートは、読者が潜在的な利益を高めるために、産業内の競争と競争環境に対する戦略を理解するのに役立ちます。また、世界のピーナッツアレルギー治療薬市場の競争環境に焦点を当て、主要企業の市場シェア、産業ランキング、競合他社のエコシステム、市場実績、新製品開発、経営状況、拡張、買収などを詳細に紹介し、読者が主要競合企業を特定し、市場の競争パターンを深く理解できるよう支援します。
本レポートは、利害関係者がピーナッツアレルギー治療薬の世界的な産業状況と動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、利害関係者が競合他社をより良く理解し、ビジネスにおける自社の地位を強化するためのより多くの洞察を得るのに役立ちます。競争環境のセクションでは、市場シェアと順位(金額)、競合他社のエコシステム、新製品開発、拡大、買収を含みます。
本レポートは、新規技術の統合、機能、市場の最新動向を常にアップデートしています。
本レポートは、利害関係者がピーナッツアレルギー治療薬業界におけるCOVID-19とロシア・ウクライナ戦争の影響力を理解するのに役立ちます。
本レポートは、利害関係者が世界的にどの地域をターゲットとすべきなのかについての洞察を得るのに役立ちます。
本レポートは、利害関係者がピーナッツアレルギー治療薬の採用に関するエンドユーザーの認識について洞察することを支援します。
本レポートは、利害関係者が市場の主要プレイヤーを特定し、その貴重な貢献度を理解するのに役立ちます。


ページTOPに戻る


目次

1 Study Coverage
1.1 Peanut Allergy Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Epinephrine Injection
1.2.3 Antihistamines
1.2.4 Oral Immunotherapy
1.2.5 Other
1.3 Market by Distribution Channel
1.3.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Distribution Channel (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Peanut Allergy Therapeutics Market Size Estimates and Forecasts
2.2 Peanut Allergy Therapeutics Market Size by Region: 2022 Versus 2028
2.2.1 Global Peanut Allergy Therapeutics Revenue by Region: 2017-2022
2.2.2 Global Peanut Allergy Therapeutics Revenue Forecast by Region (2023-2028)
2.2.3 Global Peanut Allergy Therapeutics Revenue Market Share by Region (2017-2028)
3 Global Peanut Allergy Therapeutics by Company
3.1 Global Peanut Allergy Therapeutics Revenue by Company (2017-2022)
3.2 Global Peanut Allergy Therapeutics Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Peanut Allergy Therapeutics Companies around the World: Ranking by Revenue
3.3.2 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Peanut Allergy Therapeutics Companies Headquarters & Product Type
3.4.1 Peanut Allergy Therapeutics Companies Headquarters
3.4.2 Global Peanut Allergy Therapeutics Companies Product & Service
3.4.3 Date of International Companies Enter into Peanut Allergy Therapeutics Market
3.5 Global Peanut Allergy Therapeutics Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Mylan
4.1.1 Mylan Corporation Information
4.1.2 Mylan Description, Business Overview
4.1.3 Mylan Peanut Allergy Therapeutics Products Offered
4.1.4 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.1.5 Mylan Peanut Allergy Therapeutics Revenue by Product in 2021
4.1.6 Mylan Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.1.7 Mylan Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.1.8 Mylan Recent Developments
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Peanut Allergy Therapeutics Products Offered
4.2.4 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.2.5 Bayer Peanut Allergy Therapeutics Revenue by Product in 2021
4.2.6 Bayer Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.2.7 Bayer Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.2.8 Bayer Recent Developments
4.3 UCB Pharma
4.3.1 UCB Pharma Corporation Information
4.3.2 UCB Pharma Description, Business Overview
4.3.3 UCB Pharma Peanut Allergy Therapeutics Products Offered
4.3.4 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.3.5 UCB Pharma Peanut Allergy Therapeutics Revenue by Product in 2021
4.3.6 UCB Pharma Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.3.7 UCB Pharma Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.3.8 UCB Pharma Recent Developments
4.4 J & J
4.4.1 J & J Corporation Information
4.4.2 J & J Description, Business Overview
4.4.3 J & J Peanut Allergy Therapeutics Products Offered
4.4.4 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.4.5 J & J Peanut Allergy Therapeutics Revenue by Product in 2021
4.4.6 J & J Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.4.7 J & J Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.4.8 J & J Recent Developments
4.5 Perrigo
4.5.1 Perrigo Corporation Information
4.5.2 Perrigo Description, Business Overview
4.5.3 Perrigo Peanut Allergy Therapeutics Products Offered
4.5.4 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.5.5 Perrigo Peanut Allergy Therapeutics Revenue by Product in 2021
4.5.6 Perrigo Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.5.7 Perrigo Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.5.8 Perrigo Recent Developments
4.6 GSK
4.6.1 GSK Corporation Information
4.6.2 GSK Description, Business Overview
4.6.3 GSK Peanut Allergy Therapeutics Products Offered
4.6.4 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.6.5 GSK Peanut Allergy Therapeutics Revenue by Product in 2021
4.6.6 GSK Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.6.7 GSK Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.6.8 GSK Recent Development
4.7 Kaleo
4.7.1 Kaleo Corporation Information
4.7.2 Kaleo Description, Business Overview
4.7.3 Kaleo Peanut Allergy Therapeutics Products Offered
4.7.4 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.7.5 Kaleo Peanut Allergy Therapeutics Revenue by Product in 2021
4.7.6 Kaleo Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.7.7 Kaleo Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.7.8 Kaleo Recent Development
4.8 Amneal Pharma
4.8.1 Amneal Pharma Corporation Information
4.8.2 Amneal Pharma Description, Business Overview
4.8.3 Amneal Pharma Peanut Allergy Therapeutics Products Offered
4.8.4 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.8.5 Amneal Pharma Peanut Allergy Therapeutics Revenue by Product in 2021
4.8.6 Amneal Pharma Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.8.7 Amneal Pharma Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.8.8 Amneal Pharma Recent Development
4.9 ALK Abello
4.9.1 ALK Abello Corporation Information
4.9.2 ALK Abello Description, Business Overview
4.9.3 ALK Abello Peanut Allergy Therapeutics Products Offered
4.9.4 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.9.5 ALK Abello Peanut Allergy Therapeutics Revenue by Product in 2021
4.9.6 ALK Abello Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.9.7 ALK Abello Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.9.8 ALK Abello Recent Development
4.10 Aimmune Therapeutics
4.10.1 Aimmune Therapeutics Corporation Information
4.10.2 Aimmune Therapeutics Description, Business Overview
4.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Products Offered
4.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.10.5 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021
4.10.6 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.10.7 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.10.8 Aimmune Therapeutics Recent Development
4.11 HUAPONT Pharm
4.11.1 HUAPONT Pharm Corporation Information
4.11.2 HUAPONT Pharm Description, Business Overview
4.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Products Offered
4.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.11.5 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Product in 2021
4.11.6 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.11.7 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.11.8 HUAPONT Pharm Recent Development
4.12 Allergy Therapeutics
4.12.1 Allergy Therapeutics Corporation Information
4.12.2 Allergy Therapeutics Description, Business Overview
4.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Products Offered
4.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.12.5 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021
4.12.6 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.12.7 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.12.8 Allergy Therapeutics Recent Development
4.13 ASIT Biotech
4.13.1 ASIT Biotech Corporation Information
4.13.2 ASIT Biotech Description, Business Overview
4.13.3 ASIT Biotech Peanut Allergy Therapeutics Products Offered
4.13.4 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.13.5 ASIT Biotech Peanut Allergy Therapeutics Revenue by Product in 2021
4.13.6 ASIT Biotech Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.13.7 ASIT Biotech Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.13.8 ASIT Biotech Recent Development
4.14 Sanofi
4.14.1 Sanofi Corporation Information
4.14.2 Sanofi Description, Business Overview
4.14.3 Sanofi Peanut Allergy Therapeutics Products Offered
4.14.4 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.14.5 Sanofi Peanut Allergy Therapeutics Revenue by Product in 2021
4.14.6 Sanofi Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.14.7 Sanofi Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.14.8 Sanofi Recent Development
4.15 DBV Technologies
4.15.1 DBV Technologies Corporation Information
4.15.2 DBV Technologies Description, Business Overview
4.15.3 DBV Technologies Peanut Allergy Therapeutics Products Offered
4.15.4 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.15.5 DBV Technologies Peanut Allergy Therapeutics Revenue by Product in 2021
4.15.6 DBV Technologies Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.15.7 DBV Technologies Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.15.8 DBV Technologies Recent Development
4.16 HAL Allergy
4.16.1 HAL Allergy Corporation Information
4.16.2 HAL Allergy Description, Business Overview
4.16.3 HAL Allergy Peanut Allergy Therapeutics Products Offered
4.16.4 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.16.5 HAL Allergy Peanut Allergy Therapeutics Revenue by Product in 2021
4.16.6 HAL Allergy Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.16.7 HAL Allergy Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.16.8 HAL Allergy Recent Development
4.17 Intrommune Therapeutics
4.17.1 Intrommune Therapeutics Corporation Information
4.17.2 Intrommune Therapeutics Description, Business Overview
4.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Products Offered
4.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.17.5 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021
4.17.6 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.17.7 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.17.8 Intrommune Therapeutics Recent Development
5 Breakdown Data by Type
5.1 Global Peanut Allergy Therapeutics Revenue by Type (2017-2022)
5.2 Global Peanut Allergy Therapeutics Revenue Forecast by Type (2023-2028)
5.3 Peanut Allergy Therapeutics Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Distribution Channel
6.1 Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
6.2 Global Peanut Allergy Therapeutics Revenue Forecast by Distribution Channel (2023-2028)
6.3 Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2028)
7 North America
7.1 North America Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
7.2 North America Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
7.3 North America Peanut Allergy Therapeutics Revenue by Type (2017-2022)
7.4 North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Peanut Allergy Therapeutics Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Peanut Allergy Therapeutics Revenue by Type (2017-2022)
8.4 Asia-Pacific Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
9 Europe
9.1 Europe Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
9.2 Europe Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
9.3 Europe Peanut Allergy Therapeutics Revenue by Type (2017-2022)
9.4 Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
10 Latin America
10.1 Latin America Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
10.2 Latin America Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
10.3 Latin America Peanut Allergy Therapeutics Revenue by Type (2017-2022)
10.4 Latin America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Peanut Allergy Therapeutics Revenue by Type (2017-2022)
11.4 Middle East and Africa Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Peanut Allergy Therapeutics Supply Chain Analysis
12.2 Peanut Allergy Therapeutics Key Raw Materials and Upstream Suppliers
12.3 Peanut Allergy Therapeutics Clients Analysis
12.4 Peanut Allergy Therapeutics Sales Channel and Sales Model Analysis
12.4.1 Peanut Allergy Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Peanut Allergy Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Peanut Allergy Therapeutics Distributors
13 Market Dynamics
13.1 Peanut Allergy Therapeutics Industry Trends
13.2 Peanut Allergy Therapeutics Market Drivers
13.3 Peanut Allergy Therapeutics Market Challenges
13.4 Peanut Allergy Therapeutics Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

Highlights
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Peanut Allergy Therapeutics market is projected to reach US$ 6416.9 million by 2028 from an estimated US$ 953.7 million in 2022, at a CAGR of 37.4% during 2023 and 2028.
United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics.

The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peanut Allergy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, distribution channel, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics

Product Type Insights
Global markets are presented by Peanut Allergy Therapeutics type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Peanut Allergy Therapeutics are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Peanut Allergy Therapeutics Segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other

Application Insights
This report has provided the market size (revenue data) by distribution channel, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Peanut Allergy Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Peanut Allergy Therapeutics market.
Peanut Allergy Therapeutics Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Peanut Allergy Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Peanut Allergy Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Peanut Allergy Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Epinephrine Injection
1.2.3 Antihistamines
1.2.4 Oral Immunotherapy
1.2.5 Other
1.3 Market by Distribution Channel
1.3.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Distribution Channel (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Peanut Allergy Therapeutics Market Size Estimates and Forecasts
2.2 Peanut Allergy Therapeutics Market Size by Region: 2022 Versus 2028
2.2.1 Global Peanut Allergy Therapeutics Revenue by Region: 2017-2022
2.2.2 Global Peanut Allergy Therapeutics Revenue Forecast by Region (2023-2028)
2.2.3 Global Peanut Allergy Therapeutics Revenue Market Share by Region (2017-2028)
3 Global Peanut Allergy Therapeutics by Company
3.1 Global Peanut Allergy Therapeutics Revenue by Company (2017-2022)
3.2 Global Peanut Allergy Therapeutics Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Peanut Allergy Therapeutics Companies around the World: Ranking by Revenue
3.3.2 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Peanut Allergy Therapeutics Companies Headquarters & Product Type
3.4.1 Peanut Allergy Therapeutics Companies Headquarters
3.4.2 Global Peanut Allergy Therapeutics Companies Product & Service
3.4.3 Date of International Companies Enter into Peanut Allergy Therapeutics Market
3.5 Global Peanut Allergy Therapeutics Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Mylan
4.1.1 Mylan Corporation Information
4.1.2 Mylan Description, Business Overview
4.1.3 Mylan Peanut Allergy Therapeutics Products Offered
4.1.4 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.1.5 Mylan Peanut Allergy Therapeutics Revenue by Product in 2021
4.1.6 Mylan Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.1.7 Mylan Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.1.8 Mylan Recent Developments
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Peanut Allergy Therapeutics Products Offered
4.2.4 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.2.5 Bayer Peanut Allergy Therapeutics Revenue by Product in 2021
4.2.6 Bayer Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.2.7 Bayer Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.2.8 Bayer Recent Developments
4.3 UCB Pharma
4.3.1 UCB Pharma Corporation Information
4.3.2 UCB Pharma Description, Business Overview
4.3.3 UCB Pharma Peanut Allergy Therapeutics Products Offered
4.3.4 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.3.5 UCB Pharma Peanut Allergy Therapeutics Revenue by Product in 2021
4.3.6 UCB Pharma Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.3.7 UCB Pharma Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.3.8 UCB Pharma Recent Developments
4.4 J & J
4.4.1 J & J Corporation Information
4.4.2 J & J Description, Business Overview
4.4.3 J & J Peanut Allergy Therapeutics Products Offered
4.4.4 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.4.5 J & J Peanut Allergy Therapeutics Revenue by Product in 2021
4.4.6 J & J Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.4.7 J & J Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.4.8 J & J Recent Developments
4.5 Perrigo
4.5.1 Perrigo Corporation Information
4.5.2 Perrigo Description, Business Overview
4.5.3 Perrigo Peanut Allergy Therapeutics Products Offered
4.5.4 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.5.5 Perrigo Peanut Allergy Therapeutics Revenue by Product in 2021
4.5.6 Perrigo Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.5.7 Perrigo Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.5.8 Perrigo Recent Developments
4.6 GSK
4.6.1 GSK Corporation Information
4.6.2 GSK Description, Business Overview
4.6.3 GSK Peanut Allergy Therapeutics Products Offered
4.6.4 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.6.5 GSK Peanut Allergy Therapeutics Revenue by Product in 2021
4.6.6 GSK Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.6.7 GSK Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.6.8 GSK Recent Development
4.7 Kaleo
4.7.1 Kaleo Corporation Information
4.7.2 Kaleo Description, Business Overview
4.7.3 Kaleo Peanut Allergy Therapeutics Products Offered
4.7.4 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.7.5 Kaleo Peanut Allergy Therapeutics Revenue by Product in 2021
4.7.6 Kaleo Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.7.7 Kaleo Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.7.8 Kaleo Recent Development
4.8 Amneal Pharma
4.8.1 Amneal Pharma Corporation Information
4.8.2 Amneal Pharma Description, Business Overview
4.8.3 Amneal Pharma Peanut Allergy Therapeutics Products Offered
4.8.4 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.8.5 Amneal Pharma Peanut Allergy Therapeutics Revenue by Product in 2021
4.8.6 Amneal Pharma Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.8.7 Amneal Pharma Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.8.8 Amneal Pharma Recent Development
4.9 ALK Abello
4.9.1 ALK Abello Corporation Information
4.9.2 ALK Abello Description, Business Overview
4.9.3 ALK Abello Peanut Allergy Therapeutics Products Offered
4.9.4 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.9.5 ALK Abello Peanut Allergy Therapeutics Revenue by Product in 2021
4.9.6 ALK Abello Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.9.7 ALK Abello Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.9.8 ALK Abello Recent Development
4.10 Aimmune Therapeutics
4.10.1 Aimmune Therapeutics Corporation Information
4.10.2 Aimmune Therapeutics Description, Business Overview
4.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Products Offered
4.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.10.5 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021
4.10.6 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.10.7 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.10.8 Aimmune Therapeutics Recent Development
4.11 HUAPONT Pharm
4.11.1 HUAPONT Pharm Corporation Information
4.11.2 HUAPONT Pharm Description, Business Overview
4.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Products Offered
4.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.11.5 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Product in 2021
4.11.6 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.11.7 HUAPONT Pharm Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.11.8 HUAPONT Pharm Recent Development
4.12 Allergy Therapeutics
4.12.1 Allergy Therapeutics Corporation Information
4.12.2 Allergy Therapeutics Description, Business Overview
4.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Products Offered
4.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.12.5 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021
4.12.6 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.12.7 Allergy Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.12.8 Allergy Therapeutics Recent Development
4.13 ASIT Biotech
4.13.1 ASIT Biotech Corporation Information
4.13.2 ASIT Biotech Description, Business Overview
4.13.3 ASIT Biotech Peanut Allergy Therapeutics Products Offered
4.13.4 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.13.5 ASIT Biotech Peanut Allergy Therapeutics Revenue by Product in 2021
4.13.6 ASIT Biotech Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.13.7 ASIT Biotech Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.13.8 ASIT Biotech Recent Development
4.14 Sanofi
4.14.1 Sanofi Corporation Information
4.14.2 Sanofi Description, Business Overview
4.14.3 Sanofi Peanut Allergy Therapeutics Products Offered
4.14.4 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.14.5 Sanofi Peanut Allergy Therapeutics Revenue by Product in 2021
4.14.6 Sanofi Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.14.7 Sanofi Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.14.8 Sanofi Recent Development
4.15 DBV Technologies
4.15.1 DBV Technologies Corporation Information
4.15.2 DBV Technologies Description, Business Overview
4.15.3 DBV Technologies Peanut Allergy Therapeutics Products Offered
4.15.4 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.15.5 DBV Technologies Peanut Allergy Therapeutics Revenue by Product in 2021
4.15.6 DBV Technologies Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.15.7 DBV Technologies Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.15.8 DBV Technologies Recent Development
4.16 HAL Allergy
4.16.1 HAL Allergy Corporation Information
4.16.2 HAL Allergy Description, Business Overview
4.16.3 HAL Allergy Peanut Allergy Therapeutics Products Offered
4.16.4 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.16.5 HAL Allergy Peanut Allergy Therapeutics Revenue by Product in 2021
4.16.6 HAL Allergy Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.16.7 HAL Allergy Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.16.8 HAL Allergy Recent Development
4.17 Intrommune Therapeutics
4.17.1 Intrommune Therapeutics Corporation Information
4.17.2 Intrommune Therapeutics Description, Business Overview
4.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Products Offered
4.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2017-2022)
4.17.5 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Product in 2021
4.17.6 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Distribution Channel in 2021
4.17.7 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue by Geographic Area in 2021
4.17.8 Intrommune Therapeutics Recent Development
5 Breakdown Data by Type
5.1 Global Peanut Allergy Therapeutics Revenue by Type (2017-2022)
5.2 Global Peanut Allergy Therapeutics Revenue Forecast by Type (2023-2028)
5.3 Peanut Allergy Therapeutics Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Distribution Channel
6.1 Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
6.2 Global Peanut Allergy Therapeutics Revenue Forecast by Distribution Channel (2023-2028)
6.3 Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2028)
7 North America
7.1 North America Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
7.2 North America Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
7.3 North America Peanut Allergy Therapeutics Revenue by Type (2017-2022)
7.4 North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Peanut Allergy Therapeutics Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Peanut Allergy Therapeutics Revenue by Type (2017-2022)
8.4 Asia-Pacific Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
9 Europe
9.1 Europe Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
9.2 Europe Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
9.3 Europe Peanut Allergy Therapeutics Revenue by Type (2017-2022)
9.4 Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
10 Latin America
10.1 Latin America Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
10.2 Latin America Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
10.3 Latin America Peanut Allergy Therapeutics Revenue by Type (2017-2022)
10.4 Latin America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Peanut Allergy Therapeutics Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Peanut Allergy Therapeutics Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Peanut Allergy Therapeutics Revenue by Type (2017-2022)
11.4 Middle East and Africa Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Peanut Allergy Therapeutics Supply Chain Analysis
12.2 Peanut Allergy Therapeutics Key Raw Materials and Upstream Suppliers
12.3 Peanut Allergy Therapeutics Clients Analysis
12.4 Peanut Allergy Therapeutics Sales Channel and Sales Model Analysis
12.4.1 Peanut Allergy Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Peanut Allergy Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Peanut Allergy Therapeutics Distributors
13 Market Dynamics
13.1 Peanut Allergy Therapeutics Industry Trends
13.2 Peanut Allergy Therapeutics Market Drivers
13.3 Peanut Allergy Therapeutics Market Challenges
13.4 Peanut Allergy Therapeutics Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(通信回線)の最新刊レポート

本レポートと同じKEY WORD(channel)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る